Related Experiment Video
Updated: Jun 24, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Alpha tocopherol use in the management of diabetic cardiomyopathy: lessons learned from randomized clinical trials
Turgay Celik1, Cagdas Yuksel, Atila Iyisoy
1Department of Cardiology, School of Medicine, Gulhane Military Medical Academy, Etlik-Ankara, Turkey. benturgay@yahoo.com
Abstract:
Although animal studies suggested that there may be a role for antioxidants (especially alpha-tocopherol) as therapy for heart failure (HF), the results obtained from human trials are disappointing. The variability in the response to antioxidant therapy may be due to genetic polymorphisms in enzymes involved in oxidative stress. We strongly believe that we do not have enough data supporting the use of antioxidant treatment in the management of HF patients, including a diabetic subset.
Related Concept Videos
Atherosclerosis III: Management
Cardiomyopathy VI: Nursing Management
Myocarditis III: Medical Management
Atherosclerosis IV: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy V: Interprofessional Care